Nanoscan (Human Serum Albumin)

Human Serum Albumin, the active ingredient in Nanoscan, is a plasma protein presented as a sterile solution for intravenous and subcutaneous use. It restores plasma oncotic pressure and is employed to treat hypoalbuminemia and to expand intravascular volume in patients with hypovolemia or fluid loss.

GNH USA supplies Nanoscan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Nanoscan is used to address conditions where plasma protein replacement or volume expansion is required. - Hypoalbuminemia: raises serum albumin levels and improves oncotic pressure. - Acute hypovolemia: expands intravascular volume to support circulatory stability. - Major burns: provides protein support and fluid balance during resuscitation. - Liver disease with ascites: helps maintain oncotic pressure and reduces fluid accumulation.

Adverse reactions may occur with albumin administration and are categorized by frequency.

Common Side Effects: - Fever or chills - Rash or urticaria - Headache - Nausea or vomiting - Mild hypotension - Transient hypertension

Serious or Rare Side Effects: - Anaphylactic or severe allergic reaction - Pulmonary edema - Thromboembolic events - Severe hypotension or circulatory collapse - Hemolysis - Acute renal failure

Human Serum Albumin should be used with careful clinical monitoring. - Fluid balance monitoring: assess volume status before and during infusion. - Serum albumin levels: measure to guide dosing and avoid overload. - Infusion rate: administer slowly to reduce risk of hypotension. - Cardiac or renal impairment: use with caution and monitor closely. - Allergy assessment: verify no known hypersensitivity to albumin products. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Albumin can interact with several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Concurrent diuretics: may precipitate hypovolemia. - ACE inhibitors or ARBs: can exacerbate hypotension. - Other volume expanders: increase risk of circulatory overload. - Blood products: may lead to fluid overload. - Agents that increase capillary permeability: amplify fluid shifts.

Moderate Interactions (Monitor Closely): - NSAIDs: potential renal function impact. - Nephrotoxic antibiotics: monitor kidney parameters. - Vasopressors: adjust dosing based on hemodynamic response. - Anticoagulants: observe for bleeding changes. - Corticosteroids: may affect fluid retention.